https://www.selleckchem.com/pr....oducts/3-3-cgamp.htm
541 U/L and aspartate aminotransferase (AST) 1.076 U/L; (6) the ALT/AST ratio was variable and ranged from 0.4 to 1.4; (7) the mean or median age of the COVID-19 patients with DILI ranged from 54.3 to 56 years; (8) the ratio of males to females was 1.8-3.41; (9) outcome was favorable for most patients, likely due to careful selection of the drugs and quick cessation of drug treatment with emerging DILI, but it was fatal in 19 patients; (1 countries reporting RUCAM-based DILI cases in COVID-19 patients included China, India, Japan, M
Like
Comment
Share
